MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    A Qualitative Approach to Extract Diagnostic Patterns of Cognitive Impairment in Parkinson’s Disease

    A. Eubank, A. Thatikala, M. Garza, H. Khan, T. Virmani, R. Dhall, J. Talburt, L. Larson-Prior, F. Prior (Little Rock, USA)

    Objective: This study distilled patterns of patient performance recognized by clinical professionals in people with Parkinson’s disease (PD) and cognitive impairment on the Montreal Cognitive…
  • 2025 International Congress

    Aberrations in Voluntary Thought Initiation: Parallels to Motor Freezing in Basal Ganglia Dysfunction

    S. Shugar, N. Choudhury, D. Nolasco, B. Carr (Gainesvile, USA)

    Objective: To explore the neurophysiological basis of impaired volitional thought initiation focusing on dorsal caudate dysfunction, aberrant pallidal-thalamic inhibition, and impaired corticostriatal integration. Background: While…
  • 2025 International Congress

    Cerebral Vasoreactivity and Neuropsychiatric Features in Parkinson’s disease.

    M. Cansino Torres, D. Ortiz Zacarias, S. Castillo Torres, R. Lopez Soto, J. Trejo Ayala, A. Infante Valenzuela, F. Gongora Rivera, B. Chavez Luevanos, I. Estrada Bellmann (Monterrey, Mexico)

    Objective: To determine cerebral vasoreactivity (CVR) in Parkinson’s disease (PD) and its association with the neuropsychiatric features of the disease. Background: Non-motor symptoms in PD…
  • 2025 International Congress

    Orthostatic Hypotension and Acute Cognitive Dysfunction in Parkinson’s Disease: Insights from fNIRS

    K. Longardner, P. Reddy, M. Skipworth, D. Salmon, K. Izzetoglu, I. Litvan (La Jolla, USA)

    Objective: To define cerebral oxygenation changes during positional cognitive testing in Parkinson’s disease (PD), comparing those with orthostatic hypotension (OH+) to those without (OH-). Background:…
  • 2025 International Congress

    Impact of Genetically Defined Ancestry on Progression of Idiopathic Parkinson’s Disease.

    J. Frost, S. Gray-Rodriguez, L. Wu, M. Lawton, Y. Ben-Shlomo, M. Hu, D. Grosset, R. Real, H. Morris (London, United Kingdom)

    Objective: To assess the impact of genetically defined ancestry on progression of idiopathic Parkinson's Disease and evaluate the contribution of known genetic variation on any…
  • 2025 International Congress

    Effects of transmembrane protein 106B genetic variations on disease progression in Parkinson’s disease

    Y. Fan, W. Zhao, X. Liang, Y. Sun, J. Wang (Shanghai, China)

    Objective: This study aimed to explore whether the variants of Transmembrane protein 106B (TMEM106B) influence clinical phenotypes’ trajectory in Parkinson’s disease (PD). Background: TMEM106B variations are…
  • 2025 International Congress

    Subthalamic versus Pallidal Temporal Interference Stimulation in Parkinson’s Disease: A Pilot Study

    J. Li, A. Li, C. Zhang (Shanghai, China)

    Objective: To investigate whether transcranial temporal interference stimulation (tTIS) targeting different deep brain regions produces symptom-specific improvements consistent with established deep brain stimulation (DBS) outcomes…
  • 2025 International Congress

    Unraveling Parkinson’s Disease Heterogeneity: Variability in Dopaminergic Medication Response Over Five Years – A Cluster Analysis of PPMI Data

    N. Rajabli, M. Vakhshoori, A. Espay, J. Jones, A. Baghaei, K. Dashtipour (Loma Linda, USA)

    Objective: We sought to examine which demographic, genetic, and clinical characteristics inParkinson’s disease (PD) are associated with differences in levodopa equivalent daily dose(LEDD) at five…
  • 2025 International Congress

    Developing Competency-Based Training Modules for Health Professionals in Parkinson’s Disease Management: A Review of Current Practices and Future Needs

    M. Alfeky, M. Alomari, N. Bekhit, F. Sakr, A. Hafez, O. Awadalla, M. M. Elsayed (Giza, Egypt)

    Objective: To review existing competency-based training programs for health professionals in Parkinson’s disease (PD) management and identify future educational needs to enhance patient care. Background:…
  • 2025 International Congress

    Effect of Virtual Rehabilitation Therapy on Patients with Parkinson’s Disease: A Systematic Review and Meta-Analysis

    F. Luna-Rangel, B. Gonzalez-Bedolla, C. Armengol-Garcia, D. Martinez-Ramirez (Monterrey, Mexico)

    Objective: To assess the efficacy of virtual rehabilitation therapy compared to conventional physical therapy in patients with Parkinson’s disease. Background: Rehabilitation is essential in managing…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley